Patents by Inventor Harikishore Pingali

Harikishore Pingali has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA
    Publication number: 20230089247
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation The present invention is directed towards compounds which can be useful in treating diseases such as Hyperlipidemia and also have a beneficial effect on lowering cholesterol.
    Type: Application
    Filed: December 24, 2020
    Publication date: March 23, 2023
    Inventors: Rajiv SHARMA, Sanjay KUMAR, Harikishore PINGALI, Suresh POLA, Pankaj MAKADIA, Prashant DESHMUKH, Pandurang ZAWARE, Kiran SHAH
  • NOVEL SALTS, CRYSTALLINE FORMS AND PREMIX OF HYPOLIPIDEMIC AGENT
    Publication number: 20220169603
    Abstract: Present invention relates to novel salts of saroglitazar and certain polymorphic forms of saroglitazar salts. Invention provides process for the preparation of novel salts and polymorphic forms of saroglitazar. Invention also provides novel co-precipitants or premixes of saroglitazar with pharmaceutically acceptable excipients/secondary therapeutic agent and process for the preparing same.
    Type: Application
    Filed: March 11, 2020
    Publication date: June 2, 2022
    Inventors: Rajiv Sharma, Sanjay Kumar, Brijesh Kumar Srivastava, Harikishore Pingali, Ranjeet Nair, Kalpesh Shah, Pandurang Zaware, Manoj Patel, Kamal Dave
  • OXIMINO DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA
    Publication number: 20160083380
    Abstract: Compounds of the general formula (I), including their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds and the intermediates involved in their preparation.
    Type: Application
    Filed: December 15, 2014
    Publication date: March 24, 2016
    Inventors: Ranjit C. DESAI, Harikishore PINGALI
  • Compounds for the treatment of dyslipidemia and related diseases
    Patent number: 9273041
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The present invention is directed to compounds suitable for the treatment of Disease conditions such as hyperlipidemia.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: March 1, 2016
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pankaj Makadia, Vrajesh Pandya, Sairam V. V. M. Kalapatapu
  • NOVEL COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND RELATED DISEASES
    Publication number: 20150099696
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The present invention is directed to compounds suitable for the treatment of Disease conditions such as hyperlipidemia.
    Type: Application
    Filed: June 26, 2012
    Publication date: April 9, 2015
    Applicant: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pankaj Makadia, Vrajesh Pandya, Sairam V.V.M. Kalapatapu
  • COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER DISEASES
    Publication number: 20150051144
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The present invention is directed towards compounds which can be used to treat diseases such as hyperlipidemia and also have a beneficial effect on cholesterol.
    Type: Application
    Filed: September 26, 2012
    Publication date: February 19, 2015
    Inventors: Harikishore Pingali, Vrajesh Pandya
  • Heterocyclic compounds suitable for the treatment of dyslipidemia
    Patent number: 8822414
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The present invention is directed towards compounds which can be used to treat diseases such as Hyperlipidemia and also have a beneficial effect on cholesterol.
    Type: Grant
    Filed: December 26, 2011
    Date of Patent: September 2, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pankaj Makadia, Vrajesh Pandya, Sairam Kalapatapu, V.V.M., Mukul R. Jain
  • GPR 119 agonists
    Patent number: 8785463
    Abstract: The present invention relates to novel GPR 119 agonists of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: July 22, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pandurang Zaware
  • GPR 119 agonists
    Patent number: 8772302
    Abstract: The present invention relates to novel GPR 119 agonists of the general Formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, stereoisomers, and polymorphs. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds and to methods for treating one or both of diabetes and obesity using the compounds of the invention. The present invention is directed to G-protein coupled receptor (GPCR) agonists that are useful for the treatment of obesity, diabetes and related metabolic disorders.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: July 8, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pandurang Zaware, Mukul Jain
  • Oxime derivatives
    Patent number: 8742117
    Abstract: The present invention relates to novel oxime derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: June 3, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Mukul R. Jain, Pandurang Zaware
  • HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA
    Publication number: 20130281366
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The present invention is directed towards compounds which can be used to treat diseases such as Hyperlipidemia and also have a beneficial effect on cholesterol.
    Type: Application
    Filed: December 26, 2011
    Publication date: October 24, 2013
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Harikishore Pingali, Pankaj Makadia, Vrajesh Pankaj, Sairam Kalapatapu, V.V.M., Mukul R. JAIN
  • NOVEL GPR 119 AGONISTS
    Publication number: 20130252980
    Abstract: The present invention relates to novel GPR 119 agonists of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: October 5, 2011
    Publication date: September 26, 2013
    Applicant: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pandurang Zaware
  • COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND RELATED DISEASES
    Publication number: 20120252796
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: September 29, 2010
    Publication date: October 4, 2012
    Inventors: Harikishore Pingali, V.V.M. Sairam Kalapatapu, Pankaj Makadia, Mukul R. Jain
  • 1,3-dioxane carboxylic acids
    Patent number: 8268867
    Abstract: The present invention relates to novel 1,3-dioxane carboxylic acids of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Grant
    Filed: February 19, 2007
    Date of Patent: September 18, 2012
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pankaj Maganlal Makadia, Braj Bhushan Lohray, Vidya Bhushan Lohray, Pankaj Ramanbhai Patel
  • NOVEL GPR 119 AGONISTS
    Publication number: 20120122905
    Abstract: The present invention relates to novel GPR 119 agonists of the general Formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, stereoisomers, and polymorphs. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds and to methods for treating one or both of diabetes and obesity using the compounds of the invention. The present invention is directed to G-protein coupled receptor (GPCR) agonists that are useful for the treatment of obesity, diabetes and related metabolic disorders.
    Type: Application
    Filed: June 17, 2010
    Publication date: May 17, 2012
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Harikishore Pingali, Pandurang Zaware, Mukul Jain
  • NOVEL OXIME DERIVATIVES
    Publication number: 20120028996
    Abstract: The present invention relates to novel oxime derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: December 22, 2009
    Publication date: February 2, 2012
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Harikishore Pingali, Mukul R. Jain, Pandurang Zaware
  • 1,3-DIOXANE CARBOXYLIC ACIDS
    Publication number: 20100311795
    Abstract: The present invention relates to novel 1,3-dioxane carboxylic acids of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: February 19, 2007
    Publication date: December 9, 2010
    Inventors: Harikishore Pingali, Pankaj Maganlal Makadia, Braj Bhushan Lohray
  • Substituted aralkyl derivatives
    Publication number: 20090275565
    Abstract: The present invention relates to novel substituted aralkyl derivatives of the general formula (I) and (IIIa), their derivatives, their analogs, their tautomeric forms, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates, pharmaceutical compositions containing them, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: July 8, 2009
    Publication date: November 5, 2009
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Braj B. Lohray, Vidya B. Lohray, Mukul R. Jain, Sujay Basu, Harikishore Pingali, Saurin K. Raval, Preoti S. Raval
  • Novel Antidiabetic Compounds
    Publication number: 20090012069
    Abstract: Disclosed are novel compounds of general formula (I) where the symbols are as defined in the specification, their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The compounds are useful in the treatment of diabetes and related diseases.
    Type: Application
    Filed: June 24, 2005
    Publication date: January 8, 2009
    Inventors: Braj Bhushan Lohray, Vidya Bhushan Lohray, Harikishore Pingali
  • Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
    Patent number: 7348342
    Abstract: We describe substituted benzenesulfoximine compounds having anti-inflammatory activity, processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of inflammatory diseases.
    Type: Grant
    Filed: April 1, 2003
    Date of Patent: March 25, 2008
    Assignee: Cadila Healthcare Limited
    Inventors: Braj B. Lohray, Vidya B. Lohray, Mukul R. Jain, Gautam D. Patel, Harikishore Pingali